Can zanubrutinib cure cancer?

Zanubrutinib (Zanubrutinib) is a treatment for mantle cell lymphoma (MCL), macroglobulinemia (WM), Drugs for certain types of lymphoma, such as marginal zone lymphoma (MZL), chronic lymphocytic leukemia (CLL), or small lymphocytic lymphoma (SLL), belong to a class of drugs called BTK inhibitors. It can help control and reduce the growth of lymphoma cells, thereby slowing the progression of the disease and improving patients' quality of life. Zanubrutinib does not completely cure cancer. Cancer is a very complex disease, and its treatment results are affected by many factors, including the type, stage, individual differences and other related diseases of the cancer.